Group One Trading
MIRM icon

Group One Trading’s Mirum Pharmaceuticals MIRM Stock Holding History

Group One Trading’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$33K Buy
386
+16
+4% +$1.67K ﹤0.01% 5541
2026
Q2 		$43.3K Buy
+370
New +$37.1K ﹤0.01% 5487
2026
Q1 		– Sell
-872
Closed -$68.9K – 8301
2025
Q4 		$68.9K Buy
872
+640
+276% +$45.9K ﹤0.01% 5319
2025
Q3 		$17K Buy
232
+186
+404% +$11.8K ﹤0.01% 6821
2025
Q2 		$2.34K Buy
+46
New +$2.05K ﹤0.01% 7370
2023
Q4 		– Sell
-1,527
Closed -$46.2K – 7865
2023
Q3 		$48.3K Buy
1,527
+880
+136% +$24.1K ﹤0.01% 5128
2023
Q2 		$16.7K Buy
647
+347
+116% +$9.23K ﹤0.01% 6100
2023
Q1 		$7.21K Buy
+300
New +$6.84K ﹤0.01% 6122
2022
Q3 		– Sell
-500
Closed -$10K – 7949
2022
Q2 		$10K Sell
500
-1,500
-75% -$35.4K ﹤0.01% 6757
2022
Q1 		$44K Hold
2,000
– – ﹤0.01% 6187
2021
Q4 		$32K Sell
2,000
-3,000
-60% -$46.7K ﹤0.01% 6676
2021
Q3 		$100K Buy
+5,000
New +$81.3K ﹤0.01% 5911

Other funds holding MIRM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Group One Trading's MIRM Position: Q3 2026 in Review

Group One Trading increased its Mirum Pharmaceuticals (MIRM) stake by 4.3% in Q3 2026, buying an estimated $1.67K and bringing the position to 386 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #5541.

Group One Trading first reported a position in MIRM in Q3 2021 and has held it in 12 quarters since. The position peaked at $100K in Q3 2021. 147 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Group One Trading held 386 shares of Mirum Pharmaceuticals worth $33K as of Q3 2026.
  • Group One Trading bought 16 Mirum Pharmaceuticals shares in Q3 2026, an estimated $1.67K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5541 holding.
  • Group One Trading first reported a position in Mirum Pharmaceuticals in Q3 2021 and has held it in 12 quarters since.
  • Group One Trading's Mirum Pharmaceuticals position peaked at $100K in Q3 2021.
  • 147 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.